These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 1829631

  • 41. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
    Okude M, Yamanaka A, Morimoto Y, Akihama S.
    Biol Pharm Bull; 1993 May; 16(5):448-52. PubMed ID: 8364489
    [Abstract] [Full Text] [Related]

  • 42. Procoagulant activity on platelets adhered to collagen or plasma clot.
    Ilveskero S, Siljander P, Lassila R.
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):628-35. PubMed ID: 11304482
    [Abstract] [Full Text] [Related]

  • 43. The effect of thrombin on the dynamic exchange between intraplatelet and extraplatelet fibrinogen.
    Vila V, Martínez-Sales V, Réganon E, Aznar J.
    Br J Haematol; 1997 Dec; 99(3):548-54. PubMed ID: 9401064
    [Abstract] [Full Text] [Related]

  • 44. Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II).
    Kamijyo Y, Hirota-Kawadobora M, Yamauchi K, Terasawa F, Honda T, Ikeya M, Okumura N.
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):726-32. PubMed ID: 19809304
    [Abstract] [Full Text] [Related]

  • 45. A hereditary dysfibrinogenemia: fibrinogen Awaji.
    Matsuo T, Okuno S, Mukaida T, Ueshima S, Okada K, Matsuo O.
    Haemostasis; 1987 Dec; 17(1-2):89-97. PubMed ID: 3596361
    [Abstract] [Full Text] [Related]

  • 46. Decreased thrombin activity of fibrin clots prepared in cord plasma compared with adult plasma.
    Patel P, Weitz J, Brooker LA, Paes B, Mitchell L, Andrew M.
    Pediatr Res; 1996 May; 39(5):826-30. PubMed ID: 8726236
    [Abstract] [Full Text] [Related]

  • 47. ADP, thrombin, and Bothrops atrox thrombinlike enzyme in platelet-dependent fibrin retraction.
    Niewiarowski S, Stewart GJ, Nath N, Sha AT, Lieberman GE.
    Am J Physiol; 1975 Sep; 229(3):737-45. PubMed ID: 1211467
    [Abstract] [Full Text] [Related]

  • 48. B:b interactions are essential for polymerization of variant fibrinogens with impaired holes 'a'.
    Okumura N, Terasawa F, Haneishi A, Fujihara N, Hirota-Kawadobora M, Yamauchi K, Ota H, Lord ST.
    J Thromb Haemost; 2007 Dec; 5(12):2352-9. PubMed ID: 17922804
    [Abstract] [Full Text] [Related]

  • 49. Soluble fibrin is the main mediator of Staphylococcus aureus adhesion to platelets.
    Niemann S, Spehr N, Van Aken H, Morgenstern E, Peters G, Herrmann M, Kehrel BE.
    Circulation; 2004 Jul 13; 110(2):193-200. PubMed ID: 15197141
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Fibrin γ/γ' influences the secretion of fibrinolytic components and clot structure.
    Cantero M, Rojas H, Anglés-Cano E, Marchi R.
    BMC Mol Cell Biol; 2019 Nov 01; 20(1):47. PubMed ID: 31675913
    [Abstract] [Full Text] [Related]

  • 52. Fibrin-induced release of platelet serotonin.
    Orloff KG, Michaeli D.
    Am J Physiol; 1976 Aug 01; 231(2):344-50. PubMed ID: 961885
    [Abstract] [Full Text] [Related]

  • 53. Fibrinogen naples I (B beta A68T) nonsubstrate thrombin-binding capacities.
    Meh DA, Mosesson MW, Siebenlist KR, Simpson-Haidaris PJ, Brennan SO, DiOrio JP, Thompson K, Di Minno G.
    Thromb Res; 2001 Jul 01; 103(1):63-73. PubMed ID: 11434947
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Fibrinogen Cleveland II. An abnormal fibrinogen with defective release of fibrinopeptide A.
    Crum ED, Shainoff JR, Graham RC, Ratnoff OD.
    J Clin Invest; 1974 May 01; 53(5):1308-19. PubMed ID: 4856883
    [Abstract] [Full Text] [Related]

  • 57. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
    Yan J, Luo M, Cheng P, Liao L, Deng X, Deng D, Lin F.
    Int J Hematol; 2017 Apr 01; 105(4):506-514. PubMed ID: 27933517
    [Abstract] [Full Text] [Related]

  • 58. Establishing the Transient Mass Balance of Thrombosis: From Tissue Factor to Thrombin to Fibrin Under Venous Flow.
    Zhu S, Chen J, Diamond SL.
    Arterioscler Thromb Vasc Biol; 2018 Jul 01; 38(7):1528-1536. PubMed ID: 29724819
    [Abstract] [Full Text] [Related]

  • 59. Fibrinogen Seattle II: defective release of fibrinopeptide A in a slow clotting fibrinogen.
    Schreiber WE, Schmer G.
    Thromb Res; 1985 Jan 01; 37(1):45-52. PubMed ID: 3983901
    [Abstract] [Full Text] [Related]

  • 60. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.
    Nossel HL, Wasser J, Kaplan KL, LaGamma KS, Yudelman I, Canfield RE.
    J Clin Invest; 1979 Nov 01; 64(5):1371-8. PubMed ID: 500818
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.